These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 7498967

  • 1. 5-Hydroxytryptamine2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats.
    Watts SW, Gilbert L, Webb RC.
    Hypertension; 1995 Dec; 26(6 Pt 2):1056-9. PubMed ID: 7498967
    [Abstract] [Full Text] [Related]

  • 2. The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertensive rats.
    Watts SW, Baez M, Webb RC.
    J Pharmacol Exp Ther; 1996 May; 277(2):1103-13. PubMed ID: 8627522
    [Abstract] [Full Text] [Related]

  • 3. The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension.
    Watts SW.
    J Hypertens; 1998 Jun; 16(6):811-22. PubMed ID: 9663921
    [Abstract] [Full Text] [Related]

  • 4. Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat.
    Banes AK, Watts SW.
    Hypertension; 2001 Oct; 38(4):891-5. PubMed ID: 11641304
    [Abstract] [Full Text] [Related]

  • 5. Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension.
    Watts SW.
    Hypertension; 2002 Mar 01; 39(3):825-9. PubMed ID: 11897772
    [Abstract] [Full Text] [Related]

  • 6. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
    Watts SW, Fink GD.
    Am J Physiol; 1999 Mar 01; 276(3):H944-52. PubMed ID: 10070078
    [Abstract] [Full Text] [Related]

  • 7. 5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved.
    Davis RP, Pattison J, Thompson JM, Tiniakov R, Scrogin KE, Watts SW.
    BMC Pharmacol; 2012 May 06; 12():4. PubMed ID: 22559843
    [Abstract] [Full Text] [Related]

  • 8. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension.
    Ni W, Fink GD, Watts SW.
    J Pharmacol Exp Ther; 2007 May 06; 321(2):485-91. PubMed ID: 17289838
    [Abstract] [Full Text] [Related]

  • 9. Is functional upregulation of the 5-HT2B receptor in deoxycorticosterone acetate salt-treated rats blood pressure dependent?
    Watts SW, Harris B.
    Gen Pharmacol; 1999 Dec 06; 33(6):439-47. PubMed ID: 10647769
    [Abstract] [Full Text] [Related]

  • 10. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat.
    Russell A, Banes A, Berlin H, Fink GD, Watts SW.
    J Pharmacol Exp Ther; 2002 Oct 06; 303(1):179-87. PubMed ID: 12235249
    [Abstract] [Full Text] [Related]

  • 11. Upregulation of arterial serotonin 1B and 2B receptors in deoxycorticosterone acetate-salt hypertension.
    Banes AK, Watts SW.
    Hypertension; 2002 Feb 06; 39(2 Pt 2):394-8. PubMed ID: 11882579
    [Abstract] [Full Text] [Related]

  • 12. Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension.
    Banes AK, Watts SW.
    BMC Pharmacol; 2003 Sep 15; 3():12. PubMed ID: 12974983
    [Abstract] [Full Text] [Related]

  • 13. Vascular responses to serotonin in steroid hypertensive rats.
    Mecca TE, Webb RC.
    Hypertension; 1984 Sep 15; 6(6 Pt 1):887-92. PubMed ID: 6519745
    [Abstract] [Full Text] [Related]

  • 14. Vascular responsiveness to serotonin metabolites in mineralocorticoid hypertension.
    Thompson LP, Webb RC.
    Hypertension; 1987 Mar 15; 9(3):277-81. PubMed ID: 2434424
    [Abstract] [Full Text] [Related]

  • 15. 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats.
    MacLean MR, Sweeney G, Baird M, McCulloch KM, Houslay M, Morecroft I.
    Br J Pharmacol; 1996 Nov 15; 119(5):917-30. PubMed ID: 8922741
    [Abstract] [Full Text] [Related]

  • 16. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD, Pollock DM, Clarke N, Fuchs LC.
    Am J Physiol; 1998 Jun 15; 274(6):R1613-8. PubMed ID: 9608015
    [Abstract] [Full Text] [Related]

  • 17. Presence of vasoconstrictor 5HT1-like receptors revealed by precontraction of rabbit isolated mesenteric artery.
    Choppin A, O'Connor SE.
    Br J Pharmacol; 1995 Jan 15; 114(2):309-14. PubMed ID: 7881730
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
    Johnson RJ, Fink GD, Watts SW, Galligan JJ.
    J Hypertens; 2002 Apr 15; 20(4):665-76. PubMed ID: 11910302
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of ergonovine-induced contraction in the mesenteric artery from deoxycorticosterone acetate-salt hypertensive rat.
    Watts SW, Webb RC.
    J Pharmacol Exp Ther; 1994 May 15; 269(2):617-25. PubMed ID: 8182528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.